Business Standard

Saturday, December 28, 2024 | 01:43 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end

Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.

merck
Premium

The grandson of a sharecropper, and son of a janitor, Frazier was set to retire in 2019, but the company scrapped a policy requiring CEOs to retire at the age of 65 | Photo: Reuters

Reuters
Merck & Co Inc said on Thursday Kenneth Frazier, one of only a handful of Black executives leading major US companies, would step down as chief executive officer at the end of June to be replaced by Chief Financial Officer Robert Davis.
 
Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.
 
Davis has been CFO of Merck since 2014 and has been in charge of the company's business development, real estate and other corporate strategic functions since 2016.
 
A career healthcare executive, he was the president of Baxter International

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in